Fairvalue-Calculator Fairvalue-Calculator
EN DE

Hotel Royal Chihpen (5704) Fair Value & Analysis

Consumer Cyclical · TW · Market cap 1.3B TWD

Price21.20 TWD
Fair Value7.44 TWD
Upside-64.9%
Quality95/100
Evidence: Medium Range 6.47 TWD – 8.41 TWD

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Hotel Royal Chihpen (5704) currently trades at 21.20 TWD, while our model-based Fair Value estimate is 7.44 TWD — implying the stock looks roughly 64.9% overvalued today. We read business quality at 95/100 (high quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Hotel Royal Chihpen operates a resort hotel in Taiwan. Its resort hotel comprises guest accommodations, as well as offers recreational facilities and amenities. The company is based in Taitung, Taiwan.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Hotel Royal Chihpen (5704) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 7.44 TWD versus a price of 21.20 TWD — about −65% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 5704?
Our 21-model fair value for Hotel Royal Chihpen is 7.44 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 21.20 TWD.
What is the quality score of 5704?
Hotel Royal Chihpen has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.